Tasmanian Botanics releases first Althea product as CEO flags unique opportunity to rebuild brand by Adam Sheldon July 16, 2025July 16, 2025 Tasmanian Botanics chief executive Dan Howard has described the acquisition of Althea’s pharmaceutical assets as a […]
Nàdarra raises $140k; co-founder reflects on high share price ‘misstep’ by Adam Sheldon July 15, 2025July 15, 2025
Regulated cannabis market could add $10bn to Victoria’s economy by Adam Sheldon July 14, 2025February 21, 2026
NZMCC expands membership base so firms ‘will no longer watch from the sidelines’ by Adam Sheldon July 10, 2025July 10, 2025
James Yodgee steps away from ‘brutal’ cultivation sector to join Breathe Life Sciences by Adam Sheldon July 10, 2025July 10, 2025
Inside Germany’s medicinal cannabis market: regulation, growth and global opportunity by Adam Sheldon July 10, 2025July 10, 2025
MediCann Health reveals unpublished preclinical data on concussion trial by Adam Sheldon July 10, 2025July 10, 2025
The end of a four-year rollercoaster: Golden Days receives ODC cultivation permit by Steve Jones July 9, 2025July 9, 2025
Australia’s white label identity crisis: a story of quality, branding and margins by Michael Sassano July 8, 2025July 9, 2025
